University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial NC-HEM-10-3


A Phase l Single-Ascending Dose Study of the Safety and Pharmacokinetics (PK) of TT30 in Subjects with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Type:
Phase: Phase I
Status: Not Open (Closed)
Treatments: Other
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Casey O Connell, M.D.
Other Trial Staff:  Christine Duran, D.M., Melissa Peralta, D.M., Carol Jones, R.N., Sondra Ortiz, R.N., Teresa Olea, R.N.

Staff may log in to see study documents.







For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.